Videos / Preventing renal failure in type 2 diabetes – New options
Endocrinologist, Diabetes Specialist and Weight Loss Physician; South Sydney Medical Specialists, St George Private Hospital, Hurstville Private Hospital, Waratah Hospital, and Kareena Hospital
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
These are activities that require reflection on feedback about your work.
These are activities that use your work data to ensure quality results.
These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.
These are activities that require reflection on feedback about your work.
These are activities that use your work data to ensure quality results.
Chronic kidney disease in those with T2 Diabetes has been, until now, understood to be an inevitable, progressive disease ending with dialysis and/or transplant. Recently, clinical trials have shown that Finerenone, a mineralocorticoid antagonist, has been show to significantly delay this progressive deterioration with obvious and significant benefits both in terms of individual patient outcomes as well as, in a broader sense, the health economics of these major health issues. GPs will play a key role in the implementation of this important development in T2D management. In this lecture, Dr Bobby Chan describes the theory, evidence and practical advice on how you, the GP, can begin using this drug in suitable patients.
We’re reaching out to a very select group of GPs to get your feedback on this resource. You will be providing important input for our education team to better understand the relevance of the topic and the suitability of the resource for wider consumption by your colleagues in the GP community. By watching this lecture and filling out the short post-lecture questionnaire, you will receive:
Limited spots available on the reviewing team! We need a maximum of 200 responses to participate in this questionnaire.
This activity will close once we have reached the required number of participants, or by Monday 17 February 2025 at 5:00PM AEDT.
How to complete this activity:
LDL Management – Why it is Important
Navigating Expanded PBS Access to SGLT2i in General Practice
Cervical Cancer Prevention – Common Questions
Asthma Cases – When to Use Dual vs Triple Therapy
You have completed the Educational Activities (EA) component of this activity.
Select ‘Confirm & claim CPD‘ to confirm you have engaged with this activity in its entirety and claim your CPD.
You will be taken to explore further CPD learning available to you.